Valeo Health Pockets US$12 Million In Series B Funding
Valeo COO Nadine Karadag spoke to Inc. Arabia about the factors behind the UAE-based healthtech company's growth as well as its plans to scale across the region.
UAE-based healthtech startup Valeo Health has raised US$12 million in a Series B funding round, bringing its total investment to $20 million.
The round was led by the UAE-based private equity firm Flintera, with participation from existing and new investors, including the UAE-based venture capital (VC) Nuwa Capital, New York-based VC FJ Labs, Dubai-based VC Oryx, and UAE-based VC Mindshift Capital, as well as the UAE-based VC Oraseya.
Founded by Sundeep Sahni, Nadine Karadag, and Ankur Majumder in 2021, Valeo Health focuses on personalized, data-driven healthcare in the GCC region. The new investment will help expand Valeo’s efforts to make science-backed, tailored healthcare solutions more accessible across Saudi Arabia, the UAE, and the broader GCC.
Valeo Health’s approach to AI-powered healthcare has already seen success in the region, particularly with its at-home services and proprietary longevity technology. Karadag, co-founder and Chief Operations Officer (COO), Valeo Health, told Inc. Arabia that strong market demand, investor confidence, and customer loyalty have emerged as key drivers behind her company's latest funding round.
“Securing this $12 million Series B round was a result of several key factors: our strong market traction, the increasing demand for personalized and preventive healthcare, and the trust we've built with both customers and investors," she said. "Investors recognized our ability to integrate technology with healthcare services to provide a seamless, data-driven experience for users. Our high net promoter score (NPS) and strong customer retention were also critical proof points of our impact.”
This latest round of investment marks a pivotal moment for Valeo Health, Karadog told us, while noting that the funds will be strategically allocated across three key areas to maximize the company's impact by fueling regional expansion, technology in innovation, and allowing it to scale its service offerings. “We’re deepening our footprint in the UAE and Saudi Arabia, while also evaluating opportunities in new markets," she revealed. "Additionally, we’re enhancing our AI-driven personalization engine, expanding our at-home diagnostics capabilities."
As Valeo Health continues on its growth journey, Karadag shared some lessons from scaling a business in the fast-evolving healthtech industry. “One of the biggest lessons we’ve learned is that trust and awareness are just as important as technology when it comes to scaling a healthtech business," she shared. "Preventive healthcare requires a behavioral shift, and we’ve had to invest heavily in educating both consumers and partners about its long-term value.”
She also highlighted the significance of strategic partnerships in navigating the complex landscape of healthtech. “The healthcare landscape is fragmented, so forging strong partnerships has been critical in ensuring smooth operations and credibility.” Her advice for other founders looking to expand their businesses? “Deeply understand your market’s pain points before scaling—what works in one region might not work in another. Leverage data and customer insights to refine your offering constantly. Empower your team—empowered people will take ownership, drive innovation, and make all the difference in executing a high-growth vision.”
Pictured in image: Valeo Health team. Courtesy of Valeo Health.
